Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |